CompletedPhase 1/2

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction

Belarus10 participantsStarted 2020-08-03

Plain-language summary

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Who can participate

Age range70 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- chronic medium-severe periodontitis Exclusion Criteria: * pregnancy * breast-feeding * acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis * mental disorders

What they're measuring

number of patients cured

Timeframe: 1 month

Trial details

NCT IDNCT04446897

SponsorInstitute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Periodontitis, Chronic trials